Alzheimer's Drug Passed a Crucial Milestone

Tobias Carroll InsideHook June 12, 2024
Alzheimer's Drug Passed a Crucial Milestone
AP
An FDA advisory panel unanimously endorsed Eli Lilly's donanemab.


Comment
Show comments Hide Comments


Related Articles

Copyright © RealClearHealth, LLC
© RealClearHealth | | Go to full site